首页 > 最新文献

Global pediatrics最新文献

英文 中文
Mitigating adverse effects of antiseizure medications in pediatric drug-resistant epilepsy: an open-label single-arm study of adjunctive Epilamba® 减轻抗癫痫药物在儿童耐药癫痫中的不良反应:一项辅助Epilamba®的开放标签单臂研究
Pub Date : 2026-01-14 DOI: 10.1016/j.gpeds.2026.100320
Antonella Riva , Andrea Tagliaferri , Filippo Affaticati , Martina Giorgia Perinelli , Mattia Grasso , Alice Dainelli , Vincenzo Belcastro , Agostino Bruno , Gabriele Costantino , Pasquale Striano

Background

Managing the adverse effects associated with anti-seizure medications (ASMs) is essential for enhancing the quality of life and adherence to treatment in children with drug-resistant epilepsy. This study evaluated the potential of Epilamba®, a food supplement, in mitigating treatment-related adverse effects.

Methods

Pediatric patients with drug-resistant epilepsy on polytherapy were enrolled to receive adjunctive Epilamba® (1 sachet/day) for six months. Assessments of seizure frequency, systemic and neurological toxicity, and gastrointestinal symptoms were conducted using standardized questionnaires at baseline (T0), three months (T1), and six months (T2). Data were analyzed using the Wilcoxon signed-rank test, with significance set at p < 0.05.

Results

Twenty-five children (mean age 9.84±4.39 years) completed the study. No significant changes were observed in seizure frequency or semiology from baseline at either T1 (p = 0.42) or T2 (p = 0.23), indicating that Epilamba® did not interfere with ASM effectiveness. Systemic toxicity significantly improved at T1 (p = 0.008) and T2 (p = 0.02) compared to baseline, though no additional improvement was observed between T1 and T2 (p = 0.62). Neurotoxicity also significantly decreased at T1 (p = 0.009) and T2 (p = 0.02), with stabilization thereafter (T1 vs. T2, p = 0.6). Gastrointestinal symptoms, present in over 40% of participants at baseline, showed significant improvement only at T2 (p = 0.04).

Conclusions

Epilamba® appears effective in reducing anti-seizure medications-related adverse effects in children with drug-resistant epilepsy, with peak benefits observed within three months of treatment, maintained during the follow-up, and without compromising seizure control. Further studies may contribute to assessing the effects of Epilamba® as adjunctive therapy in pediatric drug-resistant epilepsy management.
背景:控制与抗癫痫药物相关的不良反应对于提高耐药癫痫患儿的生活质量和治疗依从性至关重要。本研究评估了一种食品补充剂Epilamba®在缓解治疗相关不良反应方面的潜力。方法对接受综合治疗的儿科耐药癫痫患者,给予辅助用药Epilamba®(1香囊/天)治疗6个月。在基线(T0)、3个月(T1)和6个月(T2)使用标准化问卷评估癫痫发作频率、全身和神经毒性以及胃肠道症状。数据分析采用Wilcoxon符号秩检验,显著性设置为p <; 0.05。结果25例患儿完成研究,平均年龄(9.84±4.39)岁。在T1 (p = 0.42)或T2 (p = 0.23)时,癫痫发作频率或符号学与基线相比均无显著变化,表明Epilamba®不会干扰ASM的有效性。与基线相比,全身毒性在T1 (p = 0.008)和T2 (p = 0.02)时显著改善,尽管在T1和T2之间没有观察到额外的改善(p = 0.62)。神经毒性也在T1 (p = 0.009)和T2 (p = 0.02)时显著降低,之后趋于稳定(T1 vs. T2, p = 0.6)。超过40%的参与者在基线时出现胃肠道症状,仅在T2时才有显著改善(p = 0.04)。结论:sepilamba®可有效减少耐药癫痫患儿抗癫痫药物相关不良反应,在治疗3个月内达到峰值,并在随访期间保持,且不影响癫痫发作控制。进一步的研究可能有助于评估Epilamba®作为儿童耐药癫痫管理辅助治疗的效果。
{"title":"Mitigating adverse effects of antiseizure medications in pediatric drug-resistant epilepsy: an open-label single-arm study of adjunctive Epilamba®","authors":"Antonella Riva ,&nbsp;Andrea Tagliaferri ,&nbsp;Filippo Affaticati ,&nbsp;Martina Giorgia Perinelli ,&nbsp;Mattia Grasso ,&nbsp;Alice Dainelli ,&nbsp;Vincenzo Belcastro ,&nbsp;Agostino Bruno ,&nbsp;Gabriele Costantino ,&nbsp;Pasquale Striano","doi":"10.1016/j.gpeds.2026.100320","DOIUrl":"10.1016/j.gpeds.2026.100320","url":null,"abstract":"<div><h3>Background</h3><div>Managing the adverse effects associated with anti-seizure medications (ASMs) is essential for enhancing the quality of life and adherence to treatment in children with drug-resistant epilepsy. This study evaluated the potential of Epilamba®, a food supplement, in mitigating treatment-related adverse effects.</div></div><div><h3>Methods</h3><div>Pediatric patients with drug-resistant epilepsy on polytherapy were enrolled to receive adjunctive Epilamba® (1 sachet/day) for six months. Assessments of seizure frequency, systemic and neurological toxicity, and gastrointestinal symptoms were conducted using standardized questionnaires at baseline (T0), three months (T1), and six months (T2). Data were analyzed using the Wilcoxon signed-rank test, with significance set at <em>p</em> &lt; 0.05.</div></div><div><h3>Results</h3><div>Twenty-five children (mean age 9.84±4.39 years) completed the study. No significant changes were observed in seizure frequency or semiology from baseline at either T1 (<em>p</em> = 0.42) or T2 (<em>p</em> = 0.23), indicating that Epilamba® did not interfere with ASM effectiveness. Systemic toxicity significantly improved at T1 (<em>p</em> = 0.008) and T2 (<em>p</em> = 0.02) compared to baseline, though no additional improvement was observed between T1 and T2 (<em>p</em> = 0.62). Neurotoxicity also significantly decreased at T1 (<em>p</em> = 0.009) and T2 (<em>p</em> = 0.02), with stabilization thereafter (T1 vs. T2, <em>p</em> = 0.6). Gastrointestinal symptoms, present in over 40% of participants at baseline, showed significant improvement only at T2 (<em>p</em> = 0.04).</div></div><div><h3>Conclusions</h3><div>Epilamba® appears effective in reducing anti-seizure medications-related adverse effects in children with drug-resistant epilepsy, with peak benefits observed within three months of treatment, maintained during the follow-up, and without compromising seizure control. Further studies may contribute to assessing the effects of Epilamba® as adjunctive therapy in pediatric drug-resistant epilepsy management.</div></div>","PeriodicalId":73173,"journal":{"name":"Global pediatrics","volume":"15 ","pages":"Article 100320"},"PeriodicalIF":0.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146037190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of rehabilitation needs, utilization patterns, and out-of-pocket costs among children with disabilities: evidence from a national survey 残疾儿童康复需求、使用模式和自付费用的预测因素:来自全国调查的证据
Pub Date : 2026-01-14 DOI: 10.1016/j.gpeds.2026.100321
Jae Eun Yang , Ah Rim Kim
This study examined predictors of rehabilitation therapy needs, utilization time, and out-of-pocket (OOP) costs among children with disabilities in South Korea. We conducted a cross-sectional secondary analysis using data from the 2020 National Survey of the Disabled, including 338 children under 18 years of age. Rehabilitation needs, weekly therapy duration, and OOP costs were analyzed using descriptive statistics, chi-square tests, and logistic regression, with duration- and cost-related analyses restricted to the subsample of 250 children currently receiving therapy. Rehabilitation needs were significantly associated with brain lesions, speech disabilities, and receipt of housing benefits. Younger age, greater disability severity, higher household income, and stronger family support were related to longer weekly therapy duration. Average monthly OOP expenditures were 186 640 KRW, with higher costs linked to increased utilization, higher income, better home accessibility, and greater perceived discrimination, while lower satisfaction with welfare projects was associated with higher costs. Logistic regression identified brain lesions (OR 7.63), speech disabilities (OR 2.44), and housing benefit receipt (OR 3.28) as strong predictors of rehabilitation needs. Despite limitations in survey weighting and measurement, these findings highlight substantial socioeconomic and disability-related disparities in rehabilitation access and financial burden. Policy efforts are needed to reduce inequities, strengthen family-centered multidisciplinary rehabilitation services, and expand equitable access for children with disabilities and their families.
本研究考察了韩国残疾儿童康复治疗需求、使用时间和自费(OOP)费用的预测因素。我们使用2020年全国残疾人调查的数据进行了横断面二次分析,其中包括338名18岁以下的儿童。采用描述性统计、卡方检验和logistic回归分析康复需求、每周治疗持续时间和面向对象的成本,持续时间和成本相关的分析仅限于目前接受治疗的250名儿童的子样本。康复需求与脑损伤、语言障碍和住房福利的领取显著相关。年龄越小、残疾严重程度越大、家庭收入越高、家庭支持越强与每周治疗时间越长有关。平均每月OOP支出为186 640韩元,较高的成本与利用率提高、收入增加、更好的家庭可及性和更大的感知歧视有关,而对福利项目的满意度较低与较高的成本有关。Logistic回归发现脑损伤(OR 7.63)、语言障碍(OR 2.44)和住房福利(OR 3.28)是康复需求的强预测因子。尽管在调查加权和测量方面存在局限性,但这些发现强调了康复机会和经济负担方面存在的重大社会经济和残疾相关差异。需要做出政策努力,减少不公平现象,加强以家庭为中心的多学科康复服务,扩大残疾儿童及其家庭的公平获取机会。
{"title":"Predictors of rehabilitation needs, utilization patterns, and out-of-pocket costs among children with disabilities: evidence from a national survey","authors":"Jae Eun Yang ,&nbsp;Ah Rim Kim","doi":"10.1016/j.gpeds.2026.100321","DOIUrl":"10.1016/j.gpeds.2026.100321","url":null,"abstract":"<div><div>This study examined predictors of rehabilitation therapy needs, utilization time, and out-of-pocket (OOP) costs among children with disabilities in South Korea. We conducted a cross-sectional secondary analysis using data from the 2020 National Survey of the Disabled, including 338 children under 18 years of age. Rehabilitation needs, weekly therapy duration, and OOP costs were analyzed using descriptive statistics, chi-square tests, and logistic regression, with duration- and cost-related analyses restricted to the subsample of 250 children currently receiving therapy. Rehabilitation needs were significantly associated with brain lesions, speech disabilities, and receipt of housing benefits. Younger age, greater disability severity, higher household income, and stronger family support were related to longer weekly therapy duration. Average monthly OOP expenditures were 186 640 KRW, with higher costs linked to increased utilization, higher income, better home accessibility, and greater perceived discrimination, while lower satisfaction with welfare projects was associated with higher costs. Logistic regression identified brain lesions (OR 7.63), speech disabilities (OR 2.44), and housing benefit receipt (OR 3.28) as strong predictors of rehabilitation needs. Despite limitations in survey weighting and measurement, these findings highlight substantial socioeconomic and disability-related disparities in rehabilitation access and financial burden. Policy efforts are needed to reduce inequities, strengthen family-centered multidisciplinary rehabilitation services, and expand equitable access for children with disabilities and their families.</div></div>","PeriodicalId":73173,"journal":{"name":"Global pediatrics","volume":"15 ","pages":"Article 100321"},"PeriodicalIF":0.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146037187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and neonatal morbidities associated with preterm birth: A three-year retrospective study at Ekiti State University Teaching Hospital, Nigeria 与早产相关的患病率和新生儿发病率:尼日利亚埃基蒂州立大学教学医院的一项为期三年的回顾性研究
Pub Date : 2026-01-12 DOI: 10.1016/j.gpeds.2026.100319
Deborah Tolulope Esan , Deborah Sewanu Alivide , Basil PerfectGodsgift Nmamdi , Adetumise Oluseyi Olajide , Ayodeji Olubunmi Ogunmuyiwa , Blessed Obem Oyama , Timothy Kayode Samson , Carlos Guillermo Ramos

Background

Preterm delivery represents a critical public health challenge as the primary cause of infant mortality and significant morbidity among survivors. This retrospective study examined preterm birth prevalence and associated complications at Ekiti State University Teaching Hospital, Nigeria.

Methods

Medical records of pregnant women receiving antenatal care and delivering between 2019–2021 were analyzed. Data included maternal characteristics, obstetric history, and neonatal outcomes, with descriptive statistics used for analysis. To assess the significance of the associations, between categorical variables, inferential statistical analyses were conducted using Chi-square test. The statistical significance was set at p < .05.

Results

The distribution of neonatal morbidities across selected maternal demographic variables showed significant variation by year of delivery (p < .05), with higher prevalence among married women, Christians, and parents with tertiary education (p < .05). Preterm birth prevalence declined significantly over the years: 20.9 % in 2019, 10.2 % in 2020, and 8.2 % in 2021 (χ² = 30.42, p < .001), indicating a downward trend and a corresponding increase in term deliveries. Maternal factors significantly associated with preterm birth included parity (p < .001), gestational age at booking (p = .042), previous cesarean section (p = .029), history of pregnancy-induced hypertension (p < .001), antepartum hemorrhage (p < .001), pre-eclampsia (p < .001), and eclampsia (p < .001). Most cases occurred among multiparous women (parity 1–4), those booking at ≤20 weeks gestation, and those with histories of pregnancy-induced hypertension or pre-eclampsia. Neonatal variables showed significant variations by year in birth weight (χ² = 180.32, p < .001) and mode of delivery (χ² = 282.28, p < .001), but not in sex (p = .999) or gestation type (p = .693). All reported morbidities (jaundice, fever, anemia, convulsion, and birth defects) were significantly associated with preterm birth (p < .05), with higher prevalence in these conditions.

Conclusion

Preterm birth prevalence declined significantly from 2019 to 2021, alongside variations in neonatal morbidities influenced by maternal demographics and obstetric factors. Targeted interventions addressing modifiable risk factors, such as early booking and management of hypertensive disorders, could further reduce preterm births and associated morbidities in similar settings.
背景:早产是婴儿死亡的主要原因,也是幸存者中重要的发病率,是一项重大的公共卫生挑战。本回顾性研究调查了尼日利亚埃基蒂州立大学教学医院的早产患病率和相关并发症。方法分析2019-2021年接受产前护理和分娩的孕妇的医疗记录。数据包括产妇特征、产科史和新生儿结局,并使用描述性统计进行分析。为了评估分类变量之间关联的显著性,采用卡方检验进行了推理统计分析。p <; 0.05为差异有统计学意义。结果新生儿发病率在选定的产妇人口统计学变量中的分布随分娩年份有显著差异(p < 0.05),在已婚妇女、基督徒和受过高等教育的父母中患病率较高(p < 0.05)。早产患病率逐年显著下降:2019年为20.9%,2020年为10.2%,2021年为8.2% (χ²= 30.42,p < .001),显示出下降趋势,足月分娩相应增加。与早产显著相关的母体因素包括胎次(p < 0.001)、分娩时胎龄(p = 0.042)、剖宫产史(p = 0.029)、妊高征史(p < 0.001)、产前出血(p < 0.001)、先兆子痫(p < 0.001)和子痫(p < 0.001)。大多数病例发生在多胎妇女(胎次1-4次),妊娠≤20周,以及有妊娠高血压或先兆子痫史的妇女。新生儿变量在出生体重(χ²= 180.32,p < .001)和分娩方式(χ²= 282.28,p < .001)方面存在显著差异,但在性别(p = .999)和妊娠类型(p = .693)方面无显著差异。所有报告的发病率(黄疸、发热、贫血、惊厥和出生缺陷)都与早产显著相关(p < 0.05),这些情况下的患病率更高。结论2019 - 2021年早产儿患病率显著下降,新生儿发病率受孕产妇人口统计学和产科因素影响。针对可改变的风险因素的有针对性的干预措施,如高血压疾病的早期预约和管理,可以进一步减少类似环境中的早产和相关发病率。
{"title":"Prevalence and neonatal morbidities associated with preterm birth: A three-year retrospective study at Ekiti State University Teaching Hospital, Nigeria","authors":"Deborah Tolulope Esan ,&nbsp;Deborah Sewanu Alivide ,&nbsp;Basil PerfectGodsgift Nmamdi ,&nbsp;Adetumise Oluseyi Olajide ,&nbsp;Ayodeji Olubunmi Ogunmuyiwa ,&nbsp;Blessed Obem Oyama ,&nbsp;Timothy Kayode Samson ,&nbsp;Carlos Guillermo Ramos","doi":"10.1016/j.gpeds.2026.100319","DOIUrl":"10.1016/j.gpeds.2026.100319","url":null,"abstract":"<div><h3>Background</h3><div>Preterm delivery represents a critical public health challenge as the primary cause of infant mortality and significant morbidity among survivors. This retrospective study examined preterm birth prevalence and associated complications at Ekiti State University Teaching Hospital, Nigeria.</div></div><div><h3>Methods</h3><div>Medical records of pregnant women receiving antenatal care and delivering between 2019–2021 were analyzed. Data included maternal characteristics, obstetric history, and neonatal outcomes, with descriptive statistics used for analysis. To assess the significance of the associations, between categorical variables, inferential statistical analyses were conducted using Chi-square test. The statistical significance was set at <em>p</em> &lt; .05.</div></div><div><h3>Results</h3><div>The distribution of neonatal morbidities across selected maternal demographic variables showed significant variation by year of delivery (<em>p</em> &lt; .05), with higher prevalence among married women, Christians, and parents with tertiary education (<em>p</em> &lt; .05). Preterm birth prevalence declined significantly over the years: 20.9 % in 2019, 10.2 % in 2020, and 8.2 % in 2021 (χ² = 30.42, <em>p</em> &lt; .001), indicating a downward trend and a corresponding increase in term deliveries. Maternal factors significantly associated with preterm birth included parity (<em>p</em> &lt; .001), gestational age at booking (<em>p</em> = .042), previous cesarean section (<em>p</em> = .029), history of pregnancy-induced hypertension (<em>p</em> &lt; .001), antepartum hemorrhage (<em>p</em> &lt; .001), pre-eclampsia (<em>p</em> &lt; .001), and eclampsia (<em>p</em> &lt; .001). Most cases occurred among multiparous women (parity 1–4), those booking at ≤20 weeks gestation, and those with histories of pregnancy-induced hypertension or pre-eclampsia. Neonatal variables showed significant variations by year in birth weight (χ² = 180.32, <em>p</em> &lt; .001) and mode of delivery (χ² = 282.28, <em>p</em> &lt; .001), but not in sex (<em>p</em> = .999) or gestation type (<em>p</em> = .693). All reported morbidities (jaundice, fever, anemia, convulsion, and birth defects) were significantly associated with preterm birth (<em>p</em> &lt; .05), with higher prevalence in these conditions.</div></div><div><h3>Conclusion</h3><div>Preterm birth prevalence declined significantly from 2019 to 2021, alongside variations in neonatal morbidities influenced by maternal demographics and obstetric factors. Targeted interventions addressing modifiable risk factors, such as early booking and management of hypertensive disorders, could further reduce preterm births and associated morbidities in similar settings.</div></div>","PeriodicalId":73173,"journal":{"name":"Global pediatrics","volume":"15 ","pages":"Article 100319"},"PeriodicalIF":0.0,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of clinical instructors performance in radiographic assessment of primary molar furcation areas: A pilot study 评价临床指导员在初磨牙分叉区影像学评估中的表现:一项初步研究
Pub Date : 2025-12-31 DOI: 10.1016/j.gpeds.2025.100317
Hyun-Joo Lim , Rojin Adabdokht , Hollis Lai, Manuel O. Lagravere Vich, Camila Pacheco-Pereira, Naeem Hedayatipoor, Ida Kornerup

Purpose and Background

This study aimed to evaluate the diagnostic performance, agreement, and consistency of pediatric dentistry instructors in radiographic diagnosis of furcation lesions. Radiographic identification of furcation lesions in primary molars is challenging due to the superimposition of anatomic features and the developing permanent tooth buds. Clinical instructors’ inconsistencies in diagnosing this lesion may compromise patient outcomes and student training.

Methods

Eight clinical instructors assessed 20 radiographs in two blinded rounds. A validated reference diagnosis dataset was established by two calibrated specialists, using paired pre-treatment and follow-up radiographs. Total and subgroup analysis was performed between instructors with and without specialty training. Diagnostic performance was measured by sensitivity, specificity, and accuracy. Agreement and consistency were evaluated using Fleiss’ and Cohen’s Kappa.

Results

Overall sensitivity, specificity, and accuracy were 0.75, 0.77, and 0.76, respectively, with no significant differences between pediatric specialists and general dentists (p = 0.79). Agreement was moderate overall (K = 0.50 - 0.59), ranging from fair to moderate in general dentists and substantial in specialists. Intra-rater consistency was substantial to almost perfect overall and in both groups (K = 0.62- 0.82).

Conclusions

Instructors demonstrated satisfactory accuracy and high intra-rater consistency in diagnosing furcation lesions, however inter-rater agreement was suboptimal. Standardized guidelines or could improve calibration and teaching reliability.
目的与背景本研究旨在评估儿科牙科教师在分叉性病变的影像学诊断中的表现、一致性和一致性。由于初生磨牙的解剖特征和恒牙的发育,对其分叉病变的x线鉴别具有挑战性。临床教师在诊断这种病变时的不一致可能会损害患者的预后和学生的培训。方法8名临床指导员对20张x线片进行盲法评估。两名校准的专家使用配对的预处理和随访x线片建立了一个有效的参考诊断数据集。在接受和未接受专业培训的教员之间进行总体和亚组分析。诊断性能通过敏感性、特异性和准确性来衡量。采用Fleiss和Cohen的Kappa评估一致性和一致性。结果总体敏感性、特异性和准确性分别为0.75、0.77和0.76,儿科专科医生与普通牙医之间差异无统计学意义(p = 0.79)。一致性总体上为中等(K = 0.50 - 0.59),在普通牙医中为一般到中等,在专科牙医中为相当。总体而言,两组的内部一致性几乎是完美的(K = 0.62- 0.82)。结论指导者对分叉病变的诊断具有较高的准确性和一致性,但对分叉病变的一致性不理想。标准化的指导方针或可以提高校准和教学的可靠性。
{"title":"Evaluation of clinical instructors performance in radiographic assessment of primary molar furcation areas: A pilot study","authors":"Hyun-Joo Lim ,&nbsp;Rojin Adabdokht ,&nbsp;Hollis Lai,&nbsp;Manuel O. Lagravere Vich,&nbsp;Camila Pacheco-Pereira,&nbsp;Naeem Hedayatipoor,&nbsp;Ida Kornerup","doi":"10.1016/j.gpeds.2025.100317","DOIUrl":"10.1016/j.gpeds.2025.100317","url":null,"abstract":"<div><h3>Purpose and Background</h3><div>This study aimed to evaluate the diagnostic performance, agreement, and consistency of pediatric dentistry instructors in radiographic diagnosis of furcation lesions. Radiographic identification of furcation lesions in primary molars is challenging due to the superimposition of anatomic features and the developing permanent tooth buds. Clinical instructors’ inconsistencies in diagnosing this lesion may compromise patient outcomes and student training.</div></div><div><h3>Methods</h3><div>Eight clinical instructors assessed 20 radiographs in two blinded rounds. A validated reference diagnosis dataset was established by two calibrated specialists, using paired pre-treatment and follow-up radiographs. Total and subgroup analysis was performed between instructors with and without specialty training. Diagnostic performance was measured by sensitivity, specificity, and accuracy. Agreement and consistency were evaluated using Fleiss’ and Cohen’s Kappa.</div></div><div><h3>Results</h3><div>Overall sensitivity, specificity, and accuracy were 0.75, 0.77, and 0.76, respectively, with no significant differences between pediatric specialists and general dentists (<em>p</em> = 0.79). Agreement was moderate overall (<em>K</em> = 0.50 - 0.59), ranging from fair to moderate in general dentists and substantial in specialists. Intra-rater consistency was substantial to almost perfect overall and in both groups (<em>K</em> = 0.62- 0.82).</div></div><div><h3>Conclusions</h3><div>Instructors demonstrated satisfactory accuracy and high intra-rater consistency in diagnosing furcation lesions, however inter-rater agreement was suboptimal. Standardized guidelines or could improve calibration and teaching reliability.</div></div>","PeriodicalId":73173,"journal":{"name":"Global pediatrics","volume":"15 ","pages":"Article 100317"},"PeriodicalIF":0.0,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146037189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleep-related breathing disorders (SRBD) and attention-deficit/hyperactivity disorder (ADHD) in children attending an orthodontic clinic: a pilot case-control study 正畸门诊儿童睡眠相关呼吸障碍(SRBD)和注意力缺陷/多动障碍(ADHD):一项试点病例对照研究
Pub Date : 2025-12-30 DOI: 10.1016/j.gpeds.2025.100318
Marie Laurent , Adelin Albert , Matthieu Thimmesch , Anne-Lise Poirrier , Annick Bruwier

Introduction

: Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder in children. Sleep-related breathing disorders (SRBD), often caused by craniofacial abnormalities narrowing the airway, may be associated with ADHD. Therefore, orthodontists involved in the diagnosis and the treatment of sleep disorders should also be concerned by ADHD. The primary objective of this study was to explore the association between SRBD and ADHD in children referred to an orthodontic clinic. The study also investigated cephalometric characteristics in these children.

Material and Methods

: This pilot case-control study included 22 children attending an orthodontic clinic: 11 ADHD children diagnosed by a neuropsychologist and 11 control children matched for age, gender, BMI, and ethnicity. Control subjects were free of ADHD according to DSM-V classification. Type 3 ventilator polygraphy and cephalometric radiographs were performed. Parents answered the pediatric sleep questionnaire regarding SRBD symptoms of their child (PSQ-SRBD). A severity score and a restricted version of it removing 6 questions on behaviour were calculated. Both scores range from 0 to 1 with high values indicative of SRBD.

Results

: ADHD children evidenced a higher PSQ-SRBD severity score than controls (0.50 ± 0.14 vs. 0.11 ± 0.11, mean difference 0.39 ± 0.16, p < 0.0001) and similarly for the restricted score (0.33 ± 0.17 vs. 0.058 ± 0.056, mean difference 0.37 ± 0.17, p = 0.0003). Ventilator polygraphy parameters although not significantly different between groups were always higher in ADHD children (e.g. ventilatory effort 17.3 ± 7.0 vs 14.5 ± 12.3%; sleep fragmentation 14.5 ± 4.8 vs 13.5 ± 7.3 micro-arousals/h). Cephalometric features were comparable but ADHD subjects showed more mandibular deviation to the left (p = 0.032).

Conclusion

: Children with ADHD were more likely to suffer from sleep-related breathing disorders according to the PSQ-SRBD severity score, although the polygraph results did not confirm this finding. As for craniofacial anomalies, they only showed more mandibular deviation to the left. ADHD is important in pediatric, ENT and orthodontic practice to manage treatment of children optimally.
注意缺陷多动障碍(ADHD)是儿童最常见的神经发育障碍。睡眠相关呼吸障碍(SRBD)通常由颅面异常导致气道狭窄引起,可能与多动症有关。因此,参与诊断和治疗睡眠障碍的正畸医生也应该关注ADHD。本研究的主要目的是探讨转诊到正畸诊所的儿童的SRBD和ADHD之间的关系。该研究还调查了这些儿童的头测量特征。材料和方法:这项试点病例对照研究包括22名在正畸诊所就诊的儿童:11名由神经心理学家诊断为多动症的儿童和11名年龄、性别、BMI和种族相匹配的对照组儿童。对照受试者按照DSM-V分类无ADHD。进行3型呼吸机多影和头颅x线片检查。家长填写儿童睡眠问卷(PSQ-SRBD)。计算出了一个严重程度分数和一个限制版本,删除了6个关于行为的问题。两个分数都在0到1之间,分数高表明患有SRBD。结果:ADHD儿童PSQ-SRBD严重程度评分高于对照组(0.50±0.14比0.11±0.11,平均差值0.39±0.16,p < 0.0001),限制评分相似(0.33±0.17比0.058±0.056,平均差值0.37±0.17,p = 0.0003)。注意缺陷多动障碍儿童的呼吸机多谱参数虽然组间无显著差异,但始终较高(如呼吸努力量17.3±7.0 vs 14.5±12.3%;睡眠破碎度14.5±4.8 vs 13.5±7.3微唤醒/h)。头部测量特征相似,但ADHD患者下颌偏左较多(p = 0.032)。结论:根据PSQ-SRBD严重程度评分,患有ADHD的儿童更有可能患有与睡眠相关的呼吸障碍,尽管测谎结果并未证实这一发现。至于颅面畸形,他们只是表现出更多的下颌向左偏移。注意缺陷多动障碍在儿科、耳鼻喉科和正畸治疗中非常重要。
{"title":"Sleep-related breathing disorders (SRBD) and attention-deficit/hyperactivity disorder (ADHD) in children attending an orthodontic clinic: a pilot case-control study","authors":"Marie Laurent ,&nbsp;Adelin Albert ,&nbsp;Matthieu Thimmesch ,&nbsp;Anne-Lise Poirrier ,&nbsp;Annick Bruwier","doi":"10.1016/j.gpeds.2025.100318","DOIUrl":"10.1016/j.gpeds.2025.100318","url":null,"abstract":"<div><h3>Introduction</h3><div><strong>:</strong> Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder in children. Sleep-related breathing disorders (SRBD), often caused by craniofacial abnormalities narrowing the airway, may be associated with ADHD. Therefore, orthodontists involved in the diagnosis and the treatment of sleep disorders should also be concerned by ADHD. The primary objective of this study was to explore the association between SRBD and ADHD in children referred to an orthodontic clinic. The study also investigated cephalometric characteristics in these children.</div></div><div><h3>Material and Methods</h3><div><strong>:</strong> This pilot case-control study included 22 children attending an orthodontic clinic: 11 ADHD children diagnosed by a neuropsychologist and 11 control children matched for age, gender, BMI, and ethnicity. Control subjects were free of ADHD according to DSM-V classification. Type 3 ventilator polygraphy and cephalometric radiographs were performed. Parents answered the pediatric sleep questionnaire regarding SRBD symptoms of their child (PSQ-SRBD). A severity score and a restricted version of it removing 6 questions on behaviour were calculated. Both scores range from 0 to 1 with high values indicative of SRBD.</div></div><div><h3>Results</h3><div><strong>:</strong> ADHD children evidenced a higher PSQ-SRBD severity score than controls (0.50 ± 0.14 vs. 0.11 ± 0.11, mean difference 0.39 ± 0.16, <em>p</em> &lt; 0.0001) and similarly for the restricted score (0.33 ± 0.17 vs. 0.058 ± 0.056, mean difference 0.37 ± 0.17, <em>p</em> = 0.0003). Ventilator polygraphy parameters although not significantly different between groups were always higher in ADHD children (e.g. ventilatory effort 17.3 ± 7.0 vs 14.5 ± 12.3%; sleep fragmentation 14.5 ± 4.8 vs 13.5 ± 7.3 micro-arousals/h). Cephalometric features were comparable but ADHD subjects showed more mandibular deviation to the left (<em>p</em> = 0.032).</div></div><div><h3>Conclusion</h3><div><strong>:</strong> Children with ADHD were more likely to suffer from sleep-related breathing disorders according to the PSQ-SRBD severity score, although the polygraph results did not confirm this finding. As for craniofacial anomalies, they only showed more mandibular deviation to the left. ADHD is important in pediatric, ENT and orthodontic practice to manage treatment of children optimally.</div></div>","PeriodicalId":73173,"journal":{"name":"Global pediatrics","volume":"15 ","pages":"Article 100318"},"PeriodicalIF":0.0,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of pediatric invasive pneumococcal disease in an inner-city tertiary care center: A 13-year study and post-pandemic insights 市中心三级保健中心儿童侵袭性肺炎球菌疾病的流行病学:一项为期13年的研究和大流行后的见解
Pub Date : 2025-12-26 DOI: 10.1016/j.gpeds.2025.100316
Sarah Habbal , Nahed Abdel-Haq , Basim Asmar , Ronald Thomas , Jocelyn Yu Ang

Background

Invasive pneumococcal disease (IPD) remains a significant cause of morbidity and mortality in children. While global IPD incidence declined during the COVID-19 pandemic due to mitigation measures, a resurgence followed the relaxation of these interventions.

Objectives

The primary objective is to describe the epidemiology of IPD at our institution after the introduction of PCV-13 and to compare trends before and after the COVID-19 pandemic.

Methods

A retrospective chart review of IPD patients ≤21 years of age admitted between January 2010 - February 2024 at the Children’s Hospital of Michigan, Detroit. Patients were further categorized into 2 groups: pre-pandemic (2016-2020) and pandemic/post-pandemic (2020-2024).

Results

143 cases were included. IPD incidence decreased during the pandemic (2020-2021) to 0.6-0.8 per 1000 hospital admissions but rebounded in 2022-2023 to 1.7-1.4 per 1,000 hospital admissions. Of 143 patients 99/143(69 %) had no known risk factor and 12/143 (8.3 %) had sickle cell disease. 73 % (90/143) were fully immunized. Pneumococcal antibodies were tested in 37 patients and 20/37(54 %) had low titers; 16/20 (80 %) were fully immunized. No statistically significant differences were observed between the two periods regarding age, gender, clinical presentation or clinical outcome (p = >0.05). However, the proportion of unimmunized children was significantly higher in the post-pandemic period (n = 8/43, 20.5 %) compared to pre-pandemic period (n = 2/49, 4.8 %; p = 0.03).

Conclusions

IPD incidence increased during the two years post COVID-19 pandemic, potentially due to decreased vaccination. Recognizing these epidemiological shifts and addressing vaccination gaps with use of updated vaccine are critical in preventing future IPD outbreaks.
背景:侵袭性肺炎球菌病(IPD)仍然是儿童发病和死亡的重要原因。在2019冠状病毒病大流行期间,由于采取了缓解措施,全球IPD发病率有所下降,但在放松这些干预措施后,IPD又卷土重来。主要目的是描述引入PCV-13后我院IPD的流行病学情况,并比较COVID-19大流行前后的趋势。方法回顾性分析2010年1月至2024年2月在底特律密歇根儿童医院住院的≤21岁的IPD患者。患者进一步分为两组:大流行前(2016-2020)和大流行/大流行后(2020-2024)。结果共纳入143例。在大流行期间(2020-2021年),IPD发病率下降至每1000例住院患者0.6-0.8例,但在2022-2023年反弹至每1000例住院患者1.7-1.4例。143例患者中有99/143(69%)没有已知的危险因素,12/143(8.3%)患有镰状细胞病。73%(90/143)完全免疫。37例患者检测了肺炎球菌抗体,其中20/37(54%)的抗体滴度低;16/20(80%)完全免疫。两期患者年龄、性别、临床表现、临床转归差异无统计学意义(p = >0.05)。然而,大流行后未接种疫苗的儿童比例(n = 8/43, 20.5%)明显高于大流行前(n = 2/49, 4.8%; p = 0.03)。结论在COVID-19大流行后的两年中,sipd发病率增加,可能与疫苗接种减少有关。认识到这些流行病学变化并通过使用更新的疫苗解决疫苗接种差距对于预防未来IPD暴发至关重要。
{"title":"Epidemiology of pediatric invasive pneumococcal disease in an inner-city tertiary care center: A 13-year study and post-pandemic insights","authors":"Sarah Habbal ,&nbsp;Nahed Abdel-Haq ,&nbsp;Basim Asmar ,&nbsp;Ronald Thomas ,&nbsp;Jocelyn Yu Ang","doi":"10.1016/j.gpeds.2025.100316","DOIUrl":"10.1016/j.gpeds.2025.100316","url":null,"abstract":"<div><h3>Background</h3><div>Invasive pneumococcal disease (IPD) remains a significant cause of morbidity and mortality in children. While global IPD incidence declined during the COVID-19 pandemic due to mitigation measures, a resurgence followed the relaxation of these interventions.</div></div><div><h3>Objectives</h3><div>The primary objective is to describe the epidemiology of IPD at our institution after the introduction of PCV-13 and to compare trends before and after the COVID-19 pandemic.</div></div><div><h3>Methods</h3><div>A retrospective chart review of IPD patients ≤21 years of age admitted between January 2010 - February 2024 at the Children’s Hospital of Michigan, Detroit. Patients were further categorized into 2 groups: pre-pandemic (2016-2020) and pandemic/post-pandemic (2020-2024).</div></div><div><h3>Results</h3><div>143 cases were included. IPD incidence decreased during the pandemic (2020-2021) to 0.6-0.8 per 1000 hospital admissions but rebounded in 2022-2023 to 1.7-1.4 per 1,000 hospital admissions. Of 143 patients 99/143(69 %) had no known risk factor and 12/143 (8.3 %) had sickle cell disease. 73 % (90/143) were fully immunized. Pneumococcal antibodies were tested in 37 patients and 20/37(54 %) had low titers; 16/20 (80 %) were fully immunized. No statistically significant differences were observed between the two periods regarding age, gender, clinical presentation or clinical outcome (<em>p</em> = &gt;0.05). However, the proportion of unimmunized children was significantly higher in the post-pandemic period (<em>n</em> = 8/43, 20.5 %) compared to pre-pandemic period (<em>n</em> = 2/49, 4.8 %; <em>p</em> = 0.03).</div></div><div><h3>Conclusions</h3><div>IPD incidence increased during the two years post COVID-19 pandemic, potentially due to decreased vaccination. Recognizing these epidemiological shifts and addressing vaccination gaps with use of updated vaccine are critical in preventing future IPD outbreaks.</div></div>","PeriodicalId":73173,"journal":{"name":"Global pediatrics","volume":"15 ","pages":"Article 100316"},"PeriodicalIF":0.0,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and determinants of scabies among school-age children in selected public primary schools of Debre Tabor town, Northwest Ethiopia: A cross-sectional study, 2023 埃塞俄比亚西北部Debre Tabor镇选定公立小学中学龄儿童疥疮患病率和决定因素:一项横断面研究,2023年
Pub Date : 2025-12-23 DOI: 10.1016/j.gpeds.2025.100315
Meron Wolanewos Asfaw , Bacha Mirkena Dhabi , Tsion Wolanewos Asfaw , Betelhem Alemu Mulugeta , Ephrem Mamo Gebrehiwot

Background

Scabies is a parasitic skin infestation affecting all ages worldwide and is classified as a neglected tropical disease. Poverty and poor hygiene drive its spread. Despite national control strategies, scabies remains prevalent in Ethiopia, yet data on its burden and risk factors among school children in Debre Tabor town are limited.

Objective

To assess the prevalence and determinants of scabies among school-age children in selected public primary schools in Debre Tabor town, Northwest Ethiopia.

Methods

Institution‑based cross‑sectional study was conducted May 5–30, 2023, among 302 school‑age children randomly selected from five primary schools. Data were collected via structured questionnaire and physical examination, with quality assured through pretesting and supervision. Entries were made in Epi‑data 4.6 and analyzed in SPSS 24. Variables with p-value < 0.25 in bivariate analysis entered multivariate logistic regression. Adjusted odds ratios (AOR) with 95% confidence intervals (CI) were reported, with significance at p-value < 0.05.

Results

The prevalence of scabies was 12.3 % (95 % CI: 9.3 %, 17.2 %). Significant factors included family size >5 (AOR = 4.2, 95 % CI: 1.20–16.35), unimproved water source (AOR = 5.3, 95 % CI: 1.38–20.22), handwashing with water only (AOR = 4.8, 95 % CI: 1.22–18.66), sharing clothes (AOR = 3.7, 95 % CI: 1.05–13.31), bed sharing (AOR = 6.5, 95 % CI: 1.40–30.50) and traveling ≥30 min to fetch water (AOR = 4.9, 95 % CI: 1.15–21.09)

Conclusion

Scabies prevalence among school-age children in Debre Tabor was high, driven by household crowding, poor hygiene, and limited water. Targeted interventions in hygiene education, safe water, and behavioral change are essential.
疥疮是一种影响全世界所有年龄层的皮肤寄生虫感染,被列为一种被忽视的热带疾病。贫困和恶劣的卫生条件推动了艾滋病的传播。尽管有国家控制战略,但疥疮在埃塞俄比亚仍然普遍存在,但关于Debre Tabor镇学龄儿童的负担和风险因素的数据有限。目的了解埃塞俄比亚西北部Debre Tabor镇部分公立小学学龄儿童疥疮患病率及其影响因素。方法基于机构的横断面研究于2023年5月5日至30日在5所小学随机抽取302名学龄儿童进行。通过结构化问卷和体格检查收集数据,通过预测和监督保证数据质量。数据在Epi - data 4.6中填写,在SPSS 24中分析。双变量分析中p值为<; 0.25的变量进入多变量logistic回归。报告了校正优势比(AOR)和95%置信区间(CI), p值为<; 0.05。结果疥疮患病率为12.3% (95% CI: 9.3%, 17.2%)。显著影响因素包括家庭规模>;5 (AOR = 4.2, 95% CI: 1.20-16.35)、水源未改善(AOR = 5.3, 95% CI: 1.38-20.22)、仅用水洗手(AOR = 4.8, 95% CI: 1.22-18.66)、共用衣服(AOR = 3.7, 95% CI: 1.05-13.31)、共用床(AOR = 6.5, 95% CI: 1.40-30.50)和步行≥30分钟取水(AOR = 4.9, 95% CI: 1.35 - 16.35)。(1.15-21.09)结论德布雷塔博尔省学龄儿童疥疮患病率较高,主要受家庭拥挤、卫生条件差和饮水限制等因素影响。在卫生教育、安全饮用水和行为改变方面有针对性的干预措施至关重要。
{"title":"Prevalence and determinants of scabies among school-age children in selected public primary schools of Debre Tabor town, Northwest Ethiopia: A cross-sectional study, 2023","authors":"Meron Wolanewos Asfaw ,&nbsp;Bacha Mirkena Dhabi ,&nbsp;Tsion Wolanewos Asfaw ,&nbsp;Betelhem Alemu Mulugeta ,&nbsp;Ephrem Mamo Gebrehiwot","doi":"10.1016/j.gpeds.2025.100315","DOIUrl":"10.1016/j.gpeds.2025.100315","url":null,"abstract":"<div><h3>Background</h3><div>Scabies is a parasitic skin infestation affecting all ages worldwide and is classified as a neglected tropical disease. Poverty and poor hygiene drive its spread. Despite national control strategies, scabies remains prevalent in Ethiopia, yet data on its burden and risk factors among school children in Debre Tabor town are limited.</div></div><div><h3>Objective</h3><div>To assess the prevalence and determinants of scabies among school-age children in selected public primary schools in Debre Tabor town, Northwest Ethiopia.</div></div><div><h3>Methods</h3><div>Institution‑based cross‑sectional study was conducted May 5–30, 2023, among 302 school‑age children randomly selected from five primary schools. Data were collected via structured questionnaire and physical examination, with quality assured through pretesting and supervision. Entries were made in Epi‑data 4.6 and analyzed in SPSS 24. Variables with <em>p-value &lt; 0.25</em> in bivariate analysis entered multivariate logistic regression. Adjusted odds ratios (AOR) with 95% confidence intervals (CI) were reported, with significance at <em>p-value &lt; 0.05</em>.</div></div><div><h3>Results</h3><div>The prevalence of scabies was 12.3 % (95 % CI: 9.3 %, 17.2 %). Significant factors included family size &gt;5 (AOR = 4.2, 95 % CI: 1.20–16.35), unimproved water source (AOR = 5.3, 95 % CI: 1.38–20.22), handwashing with water only (AOR = 4.8, 95 % CI: 1.22–18.66), sharing clothes (AOR = 3.7, 95 % CI: 1.05–13.31), bed sharing (AOR = 6.5, 95 % CI: 1.40–30.50) and traveling ≥30 min to fetch water (AOR = 4.9, 95 % CI: 1.15–21.09)</div></div><div><h3>Conclusion</h3><div>Scabies prevalence among school-age children in Debre Tabor was high, driven by household crowding, poor hygiene, and limited water. Targeted interventions in hygiene education, safe water, and behavioral change are essential.</div></div>","PeriodicalId":73173,"journal":{"name":"Global pediatrics","volume":"15 ","pages":"Article 100315"},"PeriodicalIF":0.0,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert consensus on implementation and use of caffeine in Ethiopia 关于在埃塞俄比亚实施和使用咖啡因的专家共识
Pub Date : 2025-12-18 DOI: 10.1016/j.gpeds.2025.100314
Gesit Metaferia , Mahlet Abayneh , Asrat Demtse , Hailu Berta , Bogale Worku , Daniele Trevisanuto , Corrado Moretti , Camilla Gizzi
Methylxanthines such as caffeine and aminophylline are routinely administered to prevent apnea of prematurity. Caffeine is one of the most extensively studied drugs in neonatology and, for this reason, it has been included in the World Health Organization’s list of essential medicines since 2009. Unfortunately, caffeine is still not available in many low-resource settings. In Ethiopia, its introduction has begun, but national recommendations are still lacking.
In this manuscript, we present the process and results of an international expert consensus on the use of caffeine for the prevention and treatment of apnea of prematurity, aimed at supporting its implementation as an essential drug in Ethiopian hospitals. The article's influence may extend beyond Ethiopia, serving as a model for other low- and middle-income countries seeking to integrate caffeine into their neonatal care protocols.
甲基黄嘌呤如咖啡因和氨茶碱通常用于预防早产呼吸暂停。咖啡因是新生儿学中研究最广泛的药物之一,因此,自2009年以来,它已被列入世界卫生组织的基本药物清单。不幸的是,在许多低资源环境中,咖啡因仍然无法获得。埃塞俄比亚已经开始采用这种方法,但仍缺乏全国性的建议。在这份手稿中,我们介绍了使用咖啡因预防和治疗早产儿呼吸暂停的国际专家共识的过程和结果,旨在支持其作为埃塞俄比亚医院基本药物的实施。这篇文章的影响可能会超越埃塞俄比亚,为其他寻求将咖啡因纳入新生儿护理方案的低收入和中等收入国家提供一个榜样。
{"title":"Expert consensus on implementation and use of caffeine in Ethiopia","authors":"Gesit Metaferia ,&nbsp;Mahlet Abayneh ,&nbsp;Asrat Demtse ,&nbsp;Hailu Berta ,&nbsp;Bogale Worku ,&nbsp;Daniele Trevisanuto ,&nbsp;Corrado Moretti ,&nbsp;Camilla Gizzi","doi":"10.1016/j.gpeds.2025.100314","DOIUrl":"10.1016/j.gpeds.2025.100314","url":null,"abstract":"<div><div>Methylxanthines such as caffeine and aminophylline are routinely administered to prevent apnea of prematurity. Caffeine is one of the most extensively studied drugs in neonatology and, for this reason, it has been included in the World Health Organization’s list of essential medicines since 2009. Unfortunately, caffeine is still not available in many low-resource settings. In Ethiopia, its introduction has begun, but national recommendations are still lacking.</div><div>In this manuscript, we present the process and results of an international expert consensus on the use of caffeine for the prevention and treatment of apnea of prematurity, aimed at supporting its implementation as an essential drug in Ethiopian hospitals. The article's influence may extend beyond Ethiopia, serving as a model for other low- and middle-income countries seeking to integrate caffeine into their neonatal care protocols.</div></div>","PeriodicalId":73173,"journal":{"name":"Global pediatrics","volume":"15 ","pages":"Article 100314"},"PeriodicalIF":0.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multisystem Inflammatory Syndrome in Children (MIS-C): A clinical and research overview in the framework of a personalized medicine approach 儿童多系统炎症综合征(MIS-C):个体化医疗方法框架下的临床和研究综述
Pub Date : 2025-12-18 DOI: 10.1016/j.gpeds.2025.100313
Francesca Scaltrito , Maria Teresa Grimaldi , Grazia Tolfa , Roberta De Benedetto , Domenico Adduce , Maria Pastore , Sara Cannito , Ida Giardino , Massimo Pettoello-Mantovani
Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but severe pediatric condition first identified in Europe and the United States in early 2020, following initial reports from the United Kingdom and Italy. Also known as Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS), MIS-C was rapidly recognized as a delayed, potentially life-threatening complication arising after SARS-CoV-2 infection. Unlike acute COVID-19, which is often mild or asymptomatic in children, MIS-C is characterized by a pronounced hyperinflammatory response, with symptoms typically appearing two to five weeks after the initial infection. The syndrome has raised major concern due to its potential for rapid clinical deterioration and severe multi-organ involvement, particularly affecting the cardiovascular system.
Over the past five years, a growing body of research has substantially advanced our understanding of MIS-C, encompassing its pathophysiological mechanisms, clinical presentation, diagnostic criteria, treatment strategies, and long-term outcomes. In view of the persistent epidemiology of COVID-19, this article synthesizes current knowledge within the framework of a personalized medicine approach, highlights recent insights from advanced peer-reviewed studies, and underscores the need for tailored therapeutic strategies to optimize patient care.
儿童多系统炎症综合征(MIS-C)是一种罕见但严重的儿科疾病,继英国和意大利的初步报告之后,于2020年初在欧洲和美国首次发现。MIS-C也被称为与SARS-CoV-2暂时相关的儿科炎症多系统综合征(PIMS-TS),它被迅速识别为SARS-CoV-2感染后出现的延迟的、可能危及生命的并发症。与急性COVID-19不同,急性COVID-19在儿童中通常是轻微或无症状的,misc的特点是明显的高炎症反应,症状通常在初次感染后两到五周出现。该综合征由于其潜在的快速临床恶化和严重的多器官受累,特别是影响心血管系统而引起了重大关注。在过去的五年中,越来越多的研究大大提高了我们对MIS-C的理解,包括其病理生理机制、临床表现、诊断标准、治疗策略和长期结果。鉴于COVID-19的持续流行病学,本文综合了个性化医疗方法框架内的现有知识,重点介绍了来自先进同行评审研究的最新见解,并强调需要制定量身定制的治疗策略来优化患者护理。
{"title":"Multisystem Inflammatory Syndrome in Children (MIS-C): A clinical and research overview in the framework of a personalized medicine approach","authors":"Francesca Scaltrito ,&nbsp;Maria Teresa Grimaldi ,&nbsp;Grazia Tolfa ,&nbsp;Roberta De Benedetto ,&nbsp;Domenico Adduce ,&nbsp;Maria Pastore ,&nbsp;Sara Cannito ,&nbsp;Ida Giardino ,&nbsp;Massimo Pettoello-Mantovani","doi":"10.1016/j.gpeds.2025.100313","DOIUrl":"10.1016/j.gpeds.2025.100313","url":null,"abstract":"<div><div>Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but severe pediatric condition first identified in Europe and the United States in early 2020, following initial reports from the United Kingdom and Italy. Also known as Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS), MIS-C was rapidly recognized as a delayed, potentially life-threatening complication arising after SARS-CoV-2 infection. Unlike acute COVID-19, which is often mild or asymptomatic in children, MIS-C is characterized by a pronounced hyperinflammatory response, with symptoms typically appearing two to five weeks after the initial infection. The syndrome has raised major concern due to its potential for rapid clinical deterioration and severe multi-organ involvement, particularly affecting the cardiovascular system.</div><div>Over the past five years, a growing body of research has substantially advanced our understanding of MIS-C, encompassing its pathophysiological mechanisms, clinical presentation, diagnostic criteria, treatment strategies, and long-term outcomes. In view of the persistent epidemiology of COVID-19, this article synthesizes current knowledge within the framework of a personalized medicine approach, highlights recent insights from advanced peer-reviewed studies, and underscores the need for tailored therapeutic strategies to optimize patient care.</div></div>","PeriodicalId":73173,"journal":{"name":"Global pediatrics","volume":"15 ","pages":"Article 100313"},"PeriodicalIF":0.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating clinical pharmacy into pediatric care pathways: Impact on medication safety and multidisciplinary collaboration 将临床药学纳入儿科护理途径:对用药安全和多学科合作的影响
Pub Date : 2025-12-16 DOI: 10.1016/j.gpeds.2025.100312
Laura Colonges , Coralie Reygner , Jérémy Jost , Thomas Lauvray , Christophe Piguet , Eva de Berranger , Vincent Guigonis , Stéphanie Bonnet

Background

The high number of off-label medications and the unique pharmacokinetic characteristics of children make pediatrics a complex specialty with a high risk of medication errors, in which the clinical pharmacist has an important role to play.

Objective

To develop clinical pharmacy activities and evaluate their impact in pediatric departments to improve the safety of care for hospitalized children.

Methods and settings

We created specific patient pathways and assigned clinical pharmacy activities tailored to their needs (medication reviews, pharmaceutical interviews, etc.). A satisfaction survey was distributed to patients and healthcare professionals to gather feedback on our practices. We also systematized the pharmaceutical analysis of pediatric prescriptions to detect errors early and implemented a daily pharmacist presence in the pediatric hospital. All results were recorded in an Excel® spreadsheet and analyzed.

Results

In total, 85.0 % of prescription lines were reviewed (n = 5558), and 56 pharmaceutical interventions were issued (1 per 100 lines reviewed), with an acceptance rate of 94.6 %. Additionally, 98 pharmaceutical consultations were requested. Four months after implementation, four patient pathways were created: oncology/hematology, initiation of chronic treatment (standard or extemporaneously prepared by the hospital) and hospitalization at home. Families rated the service an average of 9.0/10, and 72.4 % of healthcare professionals reported being "very satisfied" with the pharmaceutical activities.

Conclusion

Just a few months after the introduction of clinical pharmacy activities, the pharmacist is already recognized as an essential member of the team, helping to secure the care pathway of young patients. The next steps include expanding the existing pathways and creating new ones.
儿童超说明书用药数量多,药代动力学特点独特,儿科是一个复杂的专科,用药错误风险高,临床药师在其中发挥着重要作用。目的开展临床药学活动,评价其在儿科的作用,以提高住院儿童护理的安全性。方法和环境我们创建了特定的患者路径,并根据他们的需求分配了临床药学活动(药物回顾、药学访谈等)。我们向患者和医护专业人员分发了一份满意度调查,以收集对我们的做法的反馈。我们还将儿科处方的药物分析系统化,以便及早发现错误,并在儿科医院实施每日药剂师在场。所有结果记录在Excel®电子表格中并进行分析。结果共审核处方线85.0%(5558条),发放药物干预措施56项(每100条审核1项),接受率为94.6%。此外,还要求进行98次药品咨询。实施4个月后,创建了4条患者路径:肿瘤学/血液学、开始慢性治疗(标准或医院临时准备的)和在家住院。家庭对该服务的平均评价为9.0/10,72.4%的医疗保健专业人员报告对药物活动“非常满意”。结论临床药学活动引入短短几个月后,药师已被公认为团队的重要成员,有助于确保年轻患者的护理路径。接下来的步骤包括扩展现有的途径并创建新的途径。
{"title":"Integrating clinical pharmacy into pediatric care pathways: Impact on medication safety and multidisciplinary collaboration","authors":"Laura Colonges ,&nbsp;Coralie Reygner ,&nbsp;Jérémy Jost ,&nbsp;Thomas Lauvray ,&nbsp;Christophe Piguet ,&nbsp;Eva de Berranger ,&nbsp;Vincent Guigonis ,&nbsp;Stéphanie Bonnet","doi":"10.1016/j.gpeds.2025.100312","DOIUrl":"10.1016/j.gpeds.2025.100312","url":null,"abstract":"<div><h3>Background</h3><div>The high number of off-label medications and the unique pharmacokinetic characteristics of children make pediatrics a complex specialty with a high risk of medication errors, in which the clinical pharmacist has an important role to play.</div></div><div><h3>Objective</h3><div>To develop clinical pharmacy activities and evaluate their impact in pediatric departments to improve the safety of care for hospitalized children.</div></div><div><h3>Methods and settings</h3><div>We created specific patient pathways and assigned clinical pharmacy activities tailored to their needs (medication reviews, pharmaceutical interviews, etc.). A satisfaction survey was distributed to patients and healthcare professionals to gather feedback on our practices. We also systematized the pharmaceutical analysis of pediatric prescriptions to detect errors early and implemented a daily pharmacist presence in the pediatric hospital. All results were recorded in an Excel® spreadsheet and analyzed.</div></div><div><h3>Results</h3><div>In total, 85.0 % of prescription lines were reviewed (<em>n</em> = 5558), and 56 pharmaceutical interventions were issued (1 per 100 lines reviewed), with an acceptance rate of 94.6 %. Additionally, 98 pharmaceutical consultations were requested. Four months after implementation, four patient pathways were created: oncology/hematology, initiation of chronic treatment (standard or extemporaneously prepared by the hospital) and hospitalization at home. Families rated the service an average of 9.0/10, and 72.4 % of healthcare professionals reported being \"very satisfied\" with the pharmaceutical activities.</div></div><div><h3>Conclusion</h3><div>Just a few months after the introduction of clinical pharmacy activities, the pharmacist is already recognized as an essential member of the team, helping to secure the care pathway of young patients. The next steps include expanding the existing pathways and creating new ones.</div></div>","PeriodicalId":73173,"journal":{"name":"Global pediatrics","volume":"15 ","pages":"Article 100312"},"PeriodicalIF":0.0,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Global pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1